Quick answer: The idea that astaxanthin changes your hormones comes almost entirely from one small human trial and a handful of lab dish experiments, not from a large body of mainstream research. In a 2008 open label study, 42 men taking a combination supplement of astaxanthin and saw palmetto for 14 days saw total testosterone rise and DHT fall. A follow up crossover trial found DHT dropped again but the testosterone increase lost statistical significance. No published human trial has tested astaxanthin alone, without saw palmetto, on testosterone, estrogen, or DHT. For women, the human data covers PCOS and endometriosis, not hormone dominance.
Where the astaxanthin and hormones claims actually come from
Almost every claim about astaxanthin and hormones traces back to two narrow sources: a patented combination supplement tested in two small trials, and a set of dish experiments on prostate cancer cells. Neither is astaxanthin taken alone in a typical 4 mg to 12 mg capsule, which is the form most people are asking about when they search for astaxanthin side effects on hormones.
The human trials used a blend called Alphastat, later marketed as Mytosterone and then Resettin, combining astaxanthin from Haematococcus pluvialis with saw palmetto berry lipid extract from Serenoa repens (Angwafor and Anderson, 2008). The lab work looked at astaxanthin’s effect on 5-alpha-reductase, the enzyme that converts testosterone to DHT, and on prostate cancer cell signaling. Both lines of evidence get repeated online as if they proved something about a plain astaxanthin softgel. They do not, and the gap between what was tested and what gets claimed is the actual story here.
Does astaxanthin raise testosterone? What the human trials show
Two small trials have measured this, and they disagree on testosterone even though they agree on DHT.
The first, an open label dose response study, gave 42 healthy men ages 37 to 70 either 800 mg or 2000 mg per day of the astaxanthin and saw palmetto blend for 14 days (Angwafor and Anderson, 2008). Total testosterone rose significantly from baseline in both dose groups, and DHT fell significantly in both groups within three days. The study did not report how much of the 800 mg or 2000 mg dose was astaxanthin versus saw palmetto extract, so you cannot isolate astaxanthin’s individual contribution from this trial alone. It also had no placebo group, which matters for a hormone that shifts with sleep, stress, and time of day regardless of what anyone takes.
A later randomized, placebo controlled crossover trial tried to confirm this using the same type of blend, sold as Resettin, in 20 sedentary men ages 21 to 70. Each man took 800 mg or 1200 mg per day for 14 days, with a 14 day washout before crossing to the other dose. Total testosterone in the 1200 mg group came in 38.04 percent higher than placebo, but that difference did not reach statistical significance. DHT, by contrast, dropped significantly at both doses compared with placebo.
So the honest read: DHT reduction replicated across both trials. The testosterone increase did not hold up to a placebo comparison. If someone tells you astaxanthin reliably raises testosterone, that claim is stronger than the actual data supports, and it rests on a multi-ingredient blend, not on astaxanthin by itself. Anyone reading an astaxanthin testosterone reddit thread should apply the same filter: a 38 percent number that was not statistically significant is not the same as a proven effect.
Astaxanthin and DHT: the 5-alpha-reductase claim explained
The DHT story starts in a petri dish, not a person. An in vitro study exposed a cell-free enzyme system to astaxanthin and found 98 percent inhibition of 5-alpha-reductase, the enzyme that converts testosterone into DHT, at a concentration of 300 micrograms per milliliter (Anderson, 2005). Combining astaxanthin with saw palmetto lipid extract produced about 20 percent greater enzyme inhibition than saw palmetto alone. That is a real, measured result, but a concentration applied directly to an enzyme in a dish tells you nothing about what blood or tissue levels a 4 mg to 12 mg oral capsule can reach in a person.
A separate study using LNCaP prostate cancer cells found that astaxanthin reduced expression of testosterone-dependent genes and lowered dihydrotestosterone and prostate-specific antigen production in that cell line, working through the aryl hydrocarbon receptor, which cross-talks with androgen receptor signaling and induces the CYP1A1 enzyme that metabolizes steroid hormones (Montazeri-Najafabady et al., 2021). This work was aimed at prostate cancer biology, not at healthy men optimizing hormones, and it was done in cultured cells, not in a living body.
What actually connects the lab work to a person is the DHT drop seen in both human trials on the astaxanthin and saw palmetto blend described above. That is the one hormone finding here with any real human replication, and it is still tied to the combination product, not to astaxanthin on its own. If you want the fuller list of documented and rumored reactions, including skin, digestive, and dose-related effects, see our astaxanthin side effects guide.
The briefing
One honest health-science email a week
Plain-English breakdowns of supplement trials, biomarkers, and what the evidence does and does not support. Written for people who want the caveats, not the hype.
Astaxanthin and estrogen: what the same trials found
Estradiol only moved at the higher doses, and only in men. In the 2008 open label trial, estradiol dropped significantly in the 2000 mg per day group but not in the 800 mg group (Angwafor and Anderson, 2008). In the later Resettin crossover trial, estradiol fell significantly in the 1200 mg group compared with placebo. Both results came from the same category of astaxanthin and saw palmetto blend, in men, over 14 days.
That is a narrow, dose-dependent finding in a specific population using a specific product. It is not evidence that a standard astaxanthin supplement lowers estrogen in general, and it says nothing about women. “Astaxanthin and estrogen dominance” is a popular search phrase, but estrogen dominance is not a standard clinical diagnosis, and no trial has tested astaxanthin against that symptom cluster, hot flashes, bloating, mood swings, heavy periods, in anyone. Anyone extrapolating from two small male trials to a female hormone-balance product is stretching the data past what it can support.
Astaxanthin and female hormones: PCOS, endometriosis, and what is missing
The human trials in women look nothing like the male testosterone and DHT studies. They focus on fertility treatment and cellular stress, not on estrogen or progesterone swings.
A randomized, double-blind trial gave 53 women with polycystic ovary syndrome (PCOS) undergoing assisted reproduction either 12 mg of astaxanthin per day, as two 6 mg capsules, or placebo for 60 days. The trial measured endoplasmic reticulum stress markers in egg-supporting granulosa cells, not sex hormone levels directly. Astaxanthin reduced markers linked to cell stress (GRP78, CHOP, XBP1) and increased total antioxidant capacity in the fluid surrounding developing eggs. Women taking astaxanthin produced more mature eggs and higher-quality embryos, though pregnancy rates were not significantly different between groups.
A separate randomized, triple-blind trial gave 50 women with stage III or IV endometriosis 6 mg of astaxanthin daily or placebo for 12 weeks before egg retrieval. Inflammatory markers (interleukin-1 beta, interleukin-6, TNF-alpha) and oxidative stress markers improved significantly. The researchers measured baseline levels of AMH, FSH, LH, estradiol, and progesterone, but did not report how those hormones changed after treatment, so this trial cannot tell you whether astaxanthin shifted anyone’s estrogen or progesterone.
Put together, the female evidence base is about oxidative stress and egg quality in two specific fertility conditions, not about “female hormones” as the search phrase implies. No trial has measured astaxanthin’s effect on the menstrual cycle in healthy women, on hormone replacement therapy, on birth control, or during pregnancy or breastfeeding. If you fall into any of those groups, that is a real evidence gap, not a settled “it’s fine.” Our astaxanthin side effects in women guide covers the broader safety picture for cycles, pregnancy, and HRT questions in more depth.
Astaxanthin, the prostate, and hormone-sensitive conditions
The most direct hormone data outside the two human trials comes from a rat model, not a human one. Researchers induced benign prostatic hyperplasia (BPH) in castrated Sprague-Dawley rats using exogenous testosterone, then dosed the animals with astaxanthin at 20, 40, or 80 milligrams per kilogram of body weight per day, orally, for four weeks. At 40 mg/kg and 80 mg/kg, prostate tissue testosterone fell significantly compared with untreated BPH model rats, and at 40 mg/kg, prostate DHT also fell significantly.
Combined with the LNCaP cell findings above, this raises a fair question for men managing prostate cancer, BPH, or a condition treated with hormone-active medication: could astaxanthin interact with androgen-driven pathways in a way that matters clinically. The honest answer is that no human trial has tested astaxanthin in men with prostate cancer, diagnosed BPH, or on androgen deprivation therapy or finasteride-type drugs. This is exactly the kind of open question that belongs in a conversation with a urologist or oncologist before adding a supplement, not something to decide from a rat study.
One more caution on the numbers: the rat doses (20 to 80 mg per kilogram of body weight per day) do not translate directly to the flat 4 mg to 12 mg daily doses sold in human supplements. A 70 kilogram adult taking even the rats’ lowest dose proportionally would need roughly 1,400 mg a day, over a hundred times a typical bottle’s serving. Do not read the rat numbers as a reason to take more.
Astaxanthin and hormones: the evidence at a glance
| Marker | What was tested | Who | Result | Evidence strength |
|---|---|---|---|---|
| Total testosterone | Astaxanthin + saw palmetto blend, 800 to 2000 mg/day, 14 days | 42 healthy men, ages 37 to 70 | Rose significantly from baseline in both dose groups | Low: open label, no placebo, blend not pure astaxanthin |
| Total testosterone, replication | Same type of blend (Resettin), 800 or 1200 mg/day, 14 days | 20 sedentary men, ages 21 to 70 | 38.04% higher than placebo at 1200 mg, not statistically significant | Low: replication did not reach significance |
| DHT | Blend, both trials above | 42 men and 20 men (separate trials) | Fell significantly at every dose tested in both trials | Moderate: most consistently replicated result, still not isolated astaxanthin |
| Estradiol | Blend, higher dose only | 42 men and 20 men (separate trials) | Fell significantly at the higher dose in both trials | Low to moderate: dose dependent, men only |
| 5-alpha-reductase activity | Astaxanthin alone, cell-free enzyme assay | In vitro, no human subjects | 98% inhibition at 300 mcg/mL | Preclinical only, no established link to oral dose or blood level |
| Prostate tissue androgens | Astaxanthin alone, 20 to 80 mg/kg/day, 4 weeks | Castrated rats with induced BPH | Prostate testosterone and DHT fell dose-dependently | Animal only |
| Reproductive markers in women | Astaxanthin alone, 6 to 12 mg/day, 8 to 12 weeks | Women with PCOS or endometriosis, about 100 combined | Cell stress and inflammation markers improved; sex hormone changes not reported post-treatment | Low: condition-specific, not generalizable to healthy women |
What would change this answer
A few specific studies would settle most of the open questions, and none of them exist yet.
- A placebo-controlled trial testing astaxanthin alone, without saw palmetto, at a normal consumer dose of 4 mg to 12 mg per day, measuring total and free testosterone, DHT, and estradiol over at least 8 to 12 weeks.
- Any trial measuring estradiol, progesterone, LH, or FSH before and after astaxanthin in healthy women, women on hormonal birth control, or women on HRT.
- A trial longer than 14 days. Both existing male hormone trials ran two weeks, so nothing is known about what happens over months of the kind of daily use most bottles are sold for.
- A trial in men already on testosterone replacement therapy, finasteride, dutasteride, or an aromatase inhibitor, to see whether astaxanthin adds to or interferes with those drugs.
Until that data exists, the fair summary is: astaxanthin combined with saw palmetto lowered DHT in two small short male trials and raised or did not raise testosterone depending on which trial you read, astaxanthin alone has never been tested this way in humans, and female hormone data is limited to two fertility-condition trials that did not report post-treatment sex hormone levels. That is a narrower evidence base than the marketing claims around astaxanthin testosterone and astaxanthin and estrogen dominance would suggest. For dosing context across goals, see our astaxanthin dosage guide, and for the full supplement picture start with our astaxanthin supplement guide.
Frequently Asked Questions
Does astaxanthin raise or lower testosterone?
The evidence is mixed. A 2008 trial found total testosterone rose significantly in 42 men taking an astaxanthin and saw palmetto blend for 14 days. A later placebo-controlled crossover trial found a 38 percent higher testosterone level at the higher dose, but that difference was not statistically significant. No trial has tested astaxanthin alone on testosterone, so a clear yes or no answer does not exist yet.
Does astaxanthin lower DHT, and could that affect hair loss?
DHT fell significantly in both human trials that tested an astaxanthin and saw palmetto blend, and lab studies show astaxanthin inhibits the 5-alpha-reductase enzyme that produces DHT. That is the mechanism behind hair loss claims, since DHT drives androgenetic alopecia. No human trial has tested astaxanthin, alone or blended, on actual hair growth or shedding. See our astaxanthin and hair loss guide for how far that claim actually goes.
Can astaxanthin cause estrogen dominance or make it worse?
There is no trial testing astaxanthin against estrogen dominance symptoms, and estrogen dominance itself is not a standard clinical diagnosis. The only estrogen data available comes from two small male trials where estradiol fell at higher doses of an astaxanthin and saw palmetto blend. Nothing in the human research shows astaxanthin raising estrogen in anyone.
Is astaxanthin safe for women on hormone replacement therapy (HRT)?
This has not been studied. No published trial has given astaxanthin to women on HRT and measured what happens to their hormone levels or symptoms. Because astaxanthin’s only human hormone data comes from short male trials on a different product, women on HRT should treat this as an open question and check with the prescribing clinician before adding astaxanthin.
Does astaxanthin affect the kidneys the way it might affect hormones?
Kidney safety and hormone effects are separate questions with separate evidence. Astaxanthin’s kidney data comes from small trials and case reports looking at creatinine and eGFR, not from the hormone trials described here. For that specific side effect, see our astaxanthin and kidney health guide rather than assuming hormone findings apply.
What about baleno astaxanthin and hormone side effects specifically?
No published human trial has tested any single branded astaxanthin product, including Baleno, for hormone effects. The hormone data in this article comes from a specific research blend (Alphastat, Mytosterone, Resettin) combining astaxanthin with saw palmetto, not from any commercial astaxanthin-only brand. Treat brand-specific hormone claims as unverified until a brand publishes its own trial data.
Does astaxanthin cause skin side effects related to hormones?
No. The known skin change from astaxanthin and other carotenoids is a benign orange or tanned tint at higher doses over time, caused by pigment building up in skin tissue, not by a hormone shift. It reverses when intake stops. It is unrelated to the testosterone, DHT, and estrogen findings covered here.
This article is for general information and does not replace individual medical advice. Astaxanthin is a dietary supplement, not an approved treatment for any hormone condition, prostate condition, or fertility diagnosis. Talk to your doctor before starting astaxanthin if you are pregnant, breastfeeding, managing PCOS, endometriosis, prostate disease, or any hormone-related condition, or if you take testosterone therapy, finasteride, dutasteride, hormonal birth control, or HRT.


